Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 942 of 3330
Next
>>
>
23526 to 23550 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
LY2	HR+	Luminal	Erlotinib	EGFR	ErbB	33.3	uM	10380.092	0.9648	0.9525	1.4888
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	0.000171	uM	7482.091	0.9252	0.9214	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	0.000853	uM	7482.091	0.8230	0.8086	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	0.00427	uM	7482.091	0.8370	0.8244	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	0.0213	uM	7482.091	0.8115	0.7955	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	0.107	uM	7482.091	0.5508	0.4700	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	0.533	uM	7482.091	0.2881	0.0520	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	2.67	uM	7482.091	0.4343	0.3003	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	13.3	uM	7482.091	0.2720	0.0211	1.9368
MB 157	Unknown	Unknown	Erlotinib	EGFR	ErbB	66.7	uM	7482.091	0.1216	-0.3261	1.9368
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.000171	uM	7483.091	0.9813	0.9877	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.000853	uM	7483.091	0.9404	0.9601	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.00427	uM	7483.091	0.9527	0.9685	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.0213	uM	7483.091	0.9874	0.9917	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.107	uM	7483.091	0.9627	0.9752	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.533	uM	7483.091	0.7774	0.8413	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	2.67	uM	7483.091	0.3781	0.4534	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	13.3	uM	7483.091	0.1193	-0.0049	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	66.7	uM	7483.091	0.1007	-0.0587	3.0465
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.000171	uM	7484.09	0.9451	0.9579	2.6525
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.000853	uM	7484.09	0.9806	0.9853	2.6525
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.00427	uM	7484.09	0.9257	0.9427	2.6525
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.0213	uM	7484.09	1.0172	1.0129	2.6525
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.107	uM	7484.09	0.8374	0.8706	2.6525
MCF 10A	NM	Basal B	Erlotinib	EGFR	ErbB	0.533	uM	7484.09	0.6358	0.6861	2.6525

|<
<<
Previous
Page 942 of 3330
Next
>>
>
23526 to 23550 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)